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Abstract
Purpose of Review In recent years, the food addiction hypothesis of loss-of-control eating has gained traction in the field of eating
disorders. In particular, the neural process of food addiction plays a dominant role in the recently formulated “addictive appetite”
model of bulimia nervosa and binge eating disorder. Nonetheless, several components of the food addiction hypothesis, including
the presence of withdrawal and tolerance effects, as well as the proposition that some foods possess “addicting” properties,
remain highly controversial. In response, the current review synthesises existing evidence for withdrawal and tolerance effects in
people with bulimia nervosa.
Recent Findings The recent development of a validated tool to measure withdrawal from highly processed foods will aid in
measuring withdrawal symptoms and testing hypotheses related to withdrawal in the context of food addiction. We subsequently
describe preclinical and human evidence for a central insulin- and dopamine-mediated pathway by which recurrent loss-of-
control binge eating is maintained in bulimia nervosa.
Summary Evidence in populations with bulimia nervosa and loss-of-control eating provides preliminary support for the role of
food addiction in the maintenance of bulimia nervosa. Future longitudinal research is needed to develop a clearer profile of illness
progression and to clarify the extent to which dysregulation in glucose metabolism contributes to food craving and symptom
maintenance in bulimia nervosa.
Keywords Food addiction . Bulimia nervosa . Eating disorders . Sugar . Dopamine
Background
The concept of “food addiction” has received increasing at-
tention in the scientific literature of recent years. While cogent
arguments have been made against the establishment of food
addiction as a psychiatric diagnosis in its own right [1], there
is substantial evidence to suggest that processes similar to
those observed in substance abuse disorders play a significant
role in the maintenance of eating disorders in which loss of
control of eating is a feature (e.g. anorexia nervosa-binge
purge type, bulimia nervosa and binge eating disorder) [2•].
In this article, we will use bulimia nervosa (BN) as the exem-
plar. The “Addictive Appetite Model” proposes that three pri-
mary processes maintain psychopathology in BN: (1) the high
salience of palatable foods [3], which is moderated by a ge-
netic susceptibility to food approach tendencies, reduced effi-
ciency in satiation processes [4] and/or episodes of food re-
striction; (2) chronic stress and interpersonal difficulties
resulting in a deficiency of alternative rewards and a primed
stress system [5]; and (3) large swings in blood glucose,
caused by the consumption of foods with a high glycaemic
index, self-induced vomiting or insulin resistance (and insulin
omission in diabetes mellitus). These pathways may contrib-
ute to compulsive binge eating behaviour through aberrations
in dopaminergic function in a similar way to substance
addictions.
The current review presents a synthesis of the literature
investigating some of the controversial aspects of applying
the food addiction paradigm to eating disorders. For instance,
there is uncertainty as to whether tolerance and withdrawal
criteria for an addictive disorder as specified within the
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DSM-5 are met. We also present a synthesis of molecular,
preclinical, clinical and neuroimaging evidence illustrating
how fluxes in glucose and insulin moderate central dopami-
nergic functioning.
Does Bulimia Nervosa Meet DSM-5 Criteria
for an Addictive Disorder?
The DSM-5 criteria for an addictive disorder are presented in
Table 1. The extent to which BN meets these criteria has been
reviewed extensively elsewhere [6]. In his 2014 review,
Brewerton acknowledges significant phenotypic overlap be-
tween disorders of substance dependence and BN but high-
lights a paucity of systematic clinical evidence for tolerance
and withdrawal in the latter, a point frequently cited as a major
weakness of the food addiction hypothesis [7]. Much research
on tolerance and withdrawal symptoms in humans to date has
been largely anecdotal [8]. However, herein we synthesise the
evidence from new assessment methods.
Tolerance
The most compelling evidence for food tolerance is demon-
strated in animal models, as previously reviewed by Murray
et al. [9]. Rats who voluntarily overeat highly palatable food
exhibit evidence of a neural reward deficit due to downregu-
lated dopamine D2 receptors, which worsens as weight is
gained [10–12]. This decreased sensitivity to reward is direct-
ly linked to the onset of compulsive food seeking in rats [11].
Repetitive bingeing on sucrose interspersed with periods of
dietary restriction causes rats to triple their overall daily sugar
consumption [13], a finding which may be of particular im-
portance to BN as it is characterised by intermittent fasting
and binge episodes [14]. A similar downregulation of dopa-
mine D2 receptors is found in humans addicted to drugs of
abuse [15] and is thought to be a key driver of compensatory
overconsumption in the Reward Hyposensitivity Theory [16,
17]. Behavioural observations in people with substance use
disorders mirror these findings.
Individuals with BN endorse higher levels of tolerance-like
symptoms measured using the Yale Food Addiction Scale
(YFAS) [8], compared with healthy controls [18, 19]. There
are clinical reports of subthreshold BN patients initiating larg-
er and more frequent binge episodes over time [20].
Consistent with these accounts is cross-sectional evidence of
the correlation between higher bodyweight and frequency and
severity of binge eating episodes [21]. Individuals with binge-
type eating disorders endorse significantly greater levels of
eating for purposes of reward enhancement compared with
weight-matched controls [22]. Such evidence, although com-
pelling, remains indirect and is insufficient to prove the exis-
tence of tolerance in humans.
A preference for intensely sweet food and larger quan-
tities of sweeteners in individuals with BN is a character-
istic often presented as an indicator of tolerance [3,
23–25]. Furthermore, this preference remains after
ingesting a glucose load [26]. Magnetic resonance imag-
ing (MRI) studies indicate hypofunctioning of gustatory
and limbic circuitry in BN patients when tasting palatable
food compared with controls [27, 28] and compared with
individuals recovered from BN [29, 30]. This evidence is
consistent with the idea that individuals with BN ingest
more food over time because of a decreased sensitivity to
Table 1 DSM-5 criteria for an addictive disorder (American Psychiatric Association, 2013)
Criteria 1 The substance is often taken in larger amounts or over a longer period than was intended
Criteria 2 There is a persistent desire or unsuccessful efforts to cut down or control use of the substance
Criteria 3 A great deal of time is spent in activities necessary to obtain the substance, use the substance
or recover from its effects
Criteria 4 Craving or a strong desire or urge to use the substance
Criteria 5 Recurrent use of the substance despite having persistent or recurrent social or interpersonal problems caused
or exacerbated by the effects of its use
Criteria 6 Continued use of the substance despite having persistent or recurrent social or interpersonal problems caused
or exacerbated by the effects of its use
Criteria 7 Important social, occupational, or recreational activities are given up or reduced because of use of the substance
Criteria 8 Recurrent use of the substance in situations in which it is physically hazardous
Criteria 9 Tolerance, as defined by either of the following:
A. A need for markedly increased amounts of the substance to achieve intoxication or desired effect
B. A markedly diminished effect with continued use of the same amount of the substance
Criteria 10 Withdrawal, as manifested by either of the following:
A. The characteristic withdrawal syndrome for other substance
B. The substance (or a closely related substance) is taken to relieve or avoid withdrawal symptoms
Bold text indicate criteria for an addictive disorder which are discussed in depth in the current manuscript with reference to their relevance to bulimia
nervosa
Curr Addict Rep
sweet taste resulting from repeated bingeing on
hyperpalatable foods [27].
The development of impaired satiety mechanisms may be
an indirect indicator of tolerance [6, 31, 32]. For example, a
recent functional MRI (fMRI) study found that women in
remission from BN exhibited the same response to taste stim-
uli in brain regions implicated in translating sensory informa-
tion about taste into motivated behaviour, regardless of wheth-
er the individuals were hungry or sated, whilst healthy con-
trols showed an increased response to taste stimuli when hun-
gry versus when fed [33]. The authors also found an increased
amygdala response in their remitted BN sample when fed
compared to healthy controls, which they propose might pro-
ject to the hypothalamus and motivate eating in the absence of
hunger [33, 34]. It is possible that brain circuitry in BN fails to
de-value food reward when in a fed state, leading to eating
beyond metabolic need.
Five years on fromBrewerton’s 2014 review, there remains
a paucity of direct evidence of tolerance in humans in relation
to food intake and prospective, longitudinal studies are
needed.
Withdrawal Syndromes
Preliminary evidence for a withdrawal syndrome in relation-
ship to palatable food comes from animal models. There are
consistent observations of strong physical (e.g. forepaw trem-
or, teeth chattering) and psychological (e.g. aggression, anxi-
ety) withdrawal responses in rats during periods of withdrawal
from sucrose [35–37]. The same observations, however, are
not found with removal of high-fat foods [38] and have not yet
been studied with removal of highly processed foods [39•].
Neuroimaging studies show patterns consistent with this be-
havioural data. Sugar-dependent rats show a significant in-
crease in extracellular acetylcholine and a decrease in dopa-
mine release in the nucleus accumbens shell, as compared to
control groups, during a 36-h period of food deprivation [35],
effects which are similar to withdrawal from morphine, nico-
tine and alcohol.
Traditionally, withdrawal symptoms have not been clearly
defined in the context of addictive-like eating, prompting crit-
icism of the food addiction framework [40]. To date, the food
addiction field has largely relied on observational and anec-
dotal clinical reports based on small cohorts or single case
studies [41–46] and on self-reported endorsement of with-
drawal symptoms on the YFAS [18] and other withdrawal
scales [47]. Cross-sectional self-report accounts are consistent
in describing physiological symptoms of withdrawal similar
to those experienced during opiate withdrawal [8, 48].
Headaches, irritability and flu-like symptoms are reported by
individuals abstaining from sugar [42], stomach pains, muscle
spasms and shakiness by individuals abstaining or reducing
intake of carbohydrates [43, 45] and nausea by individuals
abstaining from salted food [49]. Furthermore, tiredness and
irritability have been cited as motivating factors for eating
[45], providing some suggestion of food being used as a
“pick-me-up”, or to avoid experiencing negative feelings
stemming from withdrawal.
Symptoms of psychological withdrawal are also widely
reported. Cross-sectional self-report accounts from patients
with BN reveal that most feel tension, loneliness and physical
symptoms of anxiety before a binge, and the majority feel that
their negative psychological states are alleviated whilst en-
gaged in a binge [39•]. Longitudinal studies using
Ecological Momentary Assessment technology also report
that binge eating and subsequent purging are usually preceded
by dysphoric mood states [50–52]. However, there is high
prevalence of depression and emotion dysregulation in BN
populations [53], so it is not clear whether such presentations
of low mood represent psychological withdrawal from food.
Future research should aim to elucidate whether dysphoric
mood states before bingeing are distinct frommore permanent
mood-related comorbidities, perhaps by comparing depressed
versus non-depressed individuals with BN.
The first and only tool to evaluate withdrawal in the context
of addictive-like eating has been developed recently: the
Highly Processed Food Withdrawal Scale—ProWS [39•].
This in part is derived from the premise that specific nutrition-
al ingredients are capable of triggering addictive-like re-
sponses [54]. In a pilot study, the ProWS was found to be
positively associated with elevated YFAS symptoms, BMI
and weight cycling in a community sample, and responses
on the ProWS explained an additional 11.2% of the variance
in self-reported dieting success [39•]. This tool may help dif-
ferentiate between the withdrawal effects from different types
of palatable food [55, 56].
The Impact of Glucose Metabolism
on Hedonic Eating Behaviour
Preclinical Evidence
Sweet, pa latable foods act as unconditioned rewarding stimuli
in humans and rodent models, with evidence suggesting that
merely tasting sucrose without digestion produces activation
of dopaminergic circuits within the striatum [57]. However,
there is evidence to suggest that palatable foods with a high
glycaemic index further contribute to the development of
compulsive binge eating behaviour through changes in dopa-
minergic functioning triggered by wide swings in blood glu-
cose. One candidate mechanism for this effect relates to the
interaction between insulin and dopaminergic functioning.
The role of mesolimbic dopaminergic functioning in food
approach behaviours has been reviewed extensively else-
where [58]. Dopamine-deficient mouse models exhibit severe
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aphagia leading to weight loss and death [59]. Conversely, the
stimulation of dopaminergic activity within the striatum trig-
gers food consumption in rats without enhancing “liking” re-
sponses (e.g. lip-licking and paw licking). Thus, dopaminergic
functioning is thought to hold a role in food approach behav-
iours (wanting) that is discrete from the hedonic response to
food receipt [60]. In contrast, central insulin suppresses feed-
ing [61]. It is thought that the effects of central insulin and
dopamine on food intake are not independent but rather inter-
act to regulate hedonic eating behaviour.
Dopaminergic neurons within the ventral tegmental area
(VTA) express insulin receptors [62, 63], presenting a possible
mechanism by which insulin might influence the dopaminer-
gic induction of feeding behaviour. Furthermore, central insu-
lin enhances the expression of dopamine transporter protein
within the VTAvia a protein kinase B (Akt) signalling system
[64, 65]. The enhanced expression of dopamine transporters
on the cell surface induced by insulin exposure is associated
with greater dopamine uptake [66], thus reducing levels of
synaptic dopamine.
With regard to the effects of insulin on postsynaptic dopa-
minergic signalling, in vitro studies have found that insulin
exposure invokes long-term depression of excitatory signal-
ling within VTA dopamine neurons extracted from male
C57BL/6J mice [67]. This effect appears to be long-lasting
as, once induced, the long-term depression of VTA dopamine
cells is not reversed by application of the insulin receptor
antagonist S961 or through a tyrosine kinase inhibitor, which
suppresses insulin receptor functioning [67].
The effects of central insulin on dopaminergic functioning
within the VTA likely have downstream effects in suppressing
feeding and particularly hedonic feeding. For example,
Bruijnzeel et al. [68] found that injecting insulin directly into
the VTA of female rats decreased 24-h food intake. Mebel
et al. [69] have similarly found that injecting insulin directly
into the VTA suppresses subsequent feeding in male C57BL/
6J mice; however, this effect was dependent on the hunger
status of the animals. That is, insulin in the VTA suppressed
the quantity of sweetened high-fat food consumed by sated
mice but did not affect normal chow intake in hungry mice.
This pattern of effects therefore suggests that insulin activity
in the VTA acts selectively to suppress subsequent hedonic
feeding, with weaker evidence for effects on homeostatic
feeding behaviour.
Central insulin functioning may play a role in blocking the
memory of palatable food reward or attenuating the incentive
salience of cues associated with palatable food. Evidence for
this hypothesis comes from studies demonstrating that
injecting insulin either into the cerebral ventricles [70] or
VTA [67] of rats at the time of memory retrieval reduces
condit ioned place preference for palatable food.
Furthermore, Bruijnzeel et al. [68] found that injecting insulin
at a dose of 0.005 mU/side into the VTA elevated the reward
threshold for intracranial self-stimulation, thus indicating a
reduction of reward functioning.
Evidence in Humans
Insulin resistance impacts on central dopaminergic systems in
humans. For example, Dunn et al. [71] conducted a positron
emission tomography (PET) study using the dopamine D2/D3
receptor radioligand [18F] fallypride and found that insulin
sensitivity is negatively correlated with dopamine type 2 re-
ceptor availability in the ventral striatum in a heterogeneous
sample of lean and obese women. In men, Anthony et al. [72]
found that exogenously administered insulin increases metab-
olism in the ventral striatum and prefrontal cortex, whilst de-
creasing metabolism in the right amygdala, hippocampus and
cerebellar vermis. Furthermore, the effect of insulin in increas-
ing metabolism in the ventral striatum and prefrontal cortex
was lower in insulin-resistant versus insulin-sensitive partici-
pants [72]. This pattern of findings is thus indicative of trait-
level differences in the effects of central insulin on dopami-
nergic mesolimbic regions, known to be critical for food crav-
ing and food approach behaviour [59, 73].
Interactions between insulin resistance and central do-
paminergic functioning may have functional significance
for food craving in humans. Chechlacz et al. [74], in an
fMRI study, found that people with type II diabetes
mellitus (characterised by insulin resistance) exhibit great-
er blood oxygenated level dependent (BOLD) response to
food versus non-food images in the insula, orbitofrontal
cortex (OFC) and basal ganglia, when compared to people
without diabetes mellitus. Moreover, this increased activa-
tion within the insula and OFC is positively correlated with
self-reported external eating. These findings, taken togeth-
er, thus provide evidence that insulin resistance, commonly
observed following repeated excess consumption of fruc-
tose in combination with an overall excessive energy in-
take [75], is positively correlated with a pattern of neural
response to food stimuli which is associated with greater
external cue-driven eating. However, it should be noted
that the correlational nature of these findings limits the
ability to draw firm causal inferences. Although there is
relatively less evidence regarding food craving in type I
diabetes, an fMRI study has found that insulin detemir,
which more readily enters the brain compared to standard
forms of insulin, is associated with reduced BOLD re-
sponse to food images in the bilateral insula, a brain region
associated with the regulation of appetite [76]. The authors
have speculated that insulin detemir may therefore induce a
more effective satiety reaction, thus explaining the reduced
levels of weight gain observed in people with type I dia-
betes mellitus taking insulin detemir [77].
In a related study, Jastreboff et al. [78] recruited 25men and
women in the obese weight range and 25 lean controls.
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Fasting insulin and glucose were taken to measure insulin
resistance. During a subsequent fMRI task, audio scripts de-
signed to provoke relaxing imagery or favourite food imagery
were played. Food craving was assessed before and after each
imagery trial. The degree of food craving following food im-
agery trials was positively associated with insulin resistance in
the obese, but not lean, participant group. Furthermore, the
relationship between insulin resistance and food craving with-
in the obese participant group was mediated by BOLD re-
sponses in dopaminergic regions including the VTA and
substantia nigra. These studies suggest that insulin resistance
moderates craving and associated neural circuits in response
to food-related imagery.
Thus, the above studies illustrate that interactions be-
tween central insulin and dopaminergic systems, known
to impact on feeding behaviour in animals, also regulate
food craving in humans. Whilst this evidence therefore
supports a potential mechanism linking the short- and
long-term physiological effects of sugar consumption to
food craving in humans, it is also of interest to disentangle
the effects of sweet taste on dopaminergic incentive sensi-
tisation from the physiological effects of sugar in food
approach behaviour in humans. In support of the physio-
logical effects of glucose consumption on central dopami-
nergic functioning, regardless of sweet taste, Haltia et al
[79] found that the intravenous administration of glucose,
versus placebo, was associated with increased D2 receptor
binding potential in the right caudate nucleus and bilateral
putamen in both lean and overweight women. However,
intravenous glucose administration was rather associated
with reductions in D2 receptor binding potential in the
bilateral caudate nucleus, left putamen and right thalamus
in men. It should be noted that the intravenous method of
administration employed in this study bypassed the gastro-
intestinal system, thus failing to stimulate the production of
gastrointestinal hormones, such as glucagon-like peptide 1,
which also impact on appetitive functioning [80, 81]. This
study is therefore limited in the extent to which it directly
bears upon the oral consumption of glucose versus calorie-
free sweet taste. Nonetheless, these findings provide evi-
dence for the impact of glucose on mesolimbic dopaminer-
gic functioning in the absence of sweet taste. The function-
al significance of the sexual dimorphism in brain response
is not yet clear and would be an interesting avenue for
future research.
In another PET study conducted in 19 participants with
BMIs ranging from the lean to obese weight range, dopa-
mine functioning was measured following the consump-
tion of a 75-g oral glucose drink versus a calorie-free
sucralose drink of equal volume and sweetness. Within
the lean participant group, consuming the glucose drink,
versus the calorie-free sucralose drink, was associated
with increased dopaminergic binding potential within the
ventral striatum, whilst the opposite was observed in the
obese participant group [82]. Thus, there is evidence that
glucose impacts upon dopaminergic functioning separate-
ly from the effects of sweet taste alone, with BMI modu-
lating the direction of that effect. The reduced activation
stimulated by sugar consumption in obese participants is
in line with previous evidence of downregulated striatal
response to the receipt of sugar solutions, including choc-
olate milk and milkshakes [83, 84].
There is a relative paucity of research investigating the
effects of glucose metabolism on dopamine-mediated
feeding in BN and binge eating disorder without obesity.
A recent meta-analysis of studies analysing insulin sensi-
tivity in BN and binge eating disorders has found signif-
icantly reduced insulin sensitivity in both disorders [85••].
Such insulin resistance therefore leads to greater flux in
blood glucose following the consumption of foods with a
high glycaemic index, thus potentially contributing to
food craving in a similar manner to that described above
for populations with obesity [78]. The effect of insulin
resistance on glucose flux is further exacerbated by the
wide swings in blood glucose induced by intermittent
fasting followed by objectively large binge eating epi-
sodes in people with BN [86]. Frank et al. [87] found
evidence of some trait differences in brain response to
glucose, with participants recovered from BN exhibiting
suppressed BOLD response to a glucose, versus artificial
saliva solution, in the anterior cingulate cortex and left
cuneus in comparison to the control group. However, this
study is confounded by the difference in sweet taste as
well as nutritional content (glucose versus calorie-free
liquid). It will therefore be critical to carry out similar
research to that described above for obesity in populations
with bulimia-spectrum disorders in order to clarify the
functional role of a glucose metabolism pathway in loss-
of-control binge eating versus the chronic overeating
which commonly characterises overweight and obesity.
Conclusion
The current literature review has thus far served to illustrate
the existing state of the evidence with regard to food tolerance
and withdrawal effects in BN. Additionally, preclinical and
preliminary evidence in human studies has elucidated an
insulin-dependent mechanism whereby foods with a high
glycaemic index interact with mesolimbic dopamine systems
and heighten food craving in cases of insulin dysregulation.
Nonetheless, there are several lines of evidence that should be
explored further before definite conclusions can be drawn
with regard to withdrawal and tolerance in BN and the phys-
iological mechanisms which maintain addictive responses to
palatable food.
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